Advertisement

Topics

Frontline Advances Continue in Castration-Sensitive Prostate Cancer

12:25 EDT 23 Mar 2018 | OncLive

James Luke Godwin, MD, recaps recent advancements in frontline metastatic castration-sensitive prostate cancer and highlights emerging agents with potential in this space.

Original Article: Frontline Advances Continue in Castration-Sensitive Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Frontline Advances Continue in Castration-Sensitive Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement